Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q2 2024 · 10-Q
Revenue$0.00$0.00−100.0% vs Q2 2023 Net Income-$598.35K-$598.35KN/M vs Q2 2023 EPS Diluted$0.00$0.00no prior Q2 2023 on file The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
Operating Cash Flowderived-$192,012N/M ended Jun 30, 2024 · filed Aug 19, 2024 · 50 d after period end